scanance.
Sign inGet Premium
MR

Marsh & McLennan Companies, Inc.

MRSHFinancial ServicesNASDAQ

Insurance Brokers · Last scanned Jun 1, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$26.98B
+10.3% YoY
Net Income
$4.16B
+2.5% YoY
EBITDA
$7.41B
+7.0% YoY
Free Cash Flow
$4.97B

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. Valued at $78.32B, MRSH is a large-cap name in its sector. The company operates through Risk and Insurance Services, and Consulting segments.

Key stats
Market Cap$78.32B
P/E (TTM)20.32
Fwd P/E14.36
EPS$8.00
Beta0.64
52W Change-30.8%
Dividend Yield2.21%
ROE27.6%
Analysis

On the balance sheet, MRSH has $1.61B in cash with $22.45B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $4.97B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 27.6%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $20.72B (2022) to $26.98B (2025), reflecting a 30% increase over the period.

The relatively low beta of 0.64 suggests MRSH is a less volatile holding compared to the broader index. Marsh & McLennan Companies, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing MRSH.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms